ZhiZhong (Joel) Yao
Principal, Sofinnova Partners Capital Strategy
Zhizhong (Joel) Yao joined us in 2015 as an analyst focusing on investments in the biopharmaceutical sector.
Prior to joining Sofinnova, Zhizhong carried out post-doctoral research at the French National Institute of Agricultural Research, visualizing the localization and dynamics of cytoskeletal proteins as potential new antibiotic targets.
He holds a Ph.D. in chemical biology and systems biology from Harvard University, where he developed quantitative single-cell methods to determine the mechanism of action of antibiotics as well as drug-drug/gene-drug/gene-gene interactions.
He also holds a B.S. in chemistry and molecular engineering from Peking University. Zhizhong was a teaching fellow and life-science residential advisor at Harvard College. His original research and review articles have appeared in peer-reviewed journals such as PNAS, Molecular Cell, PLoS Genetics and Annual Review of Microbiology.
Sectors
Medical Devices & Biopharmaceuticals
